Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Judith Shlay

Concepts (244)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sexually Transmitted Diseases
11
2020
168
2.210
Why?
Text Messaging
7
2022
182
2.140
Why?
School Health Services
7
2015
221
2.090
Why?
Sexual Health
6
2022
68
2.040
Why?
Immunization Programs
6
2015
193
1.930
Why?
Pregnancy in Adolescence
4
2017
82
1.450
Why?
Safety-net Providers
2
2020
130
1.110
Why?
Opioid-Related Disorders
3
2022
602
1.090
Why?
Sexual Behavior
10
2022
494
0.980
Why?
Influenza Vaccines
4
2015
534
0.970
Why?
Condoms
5
2016
102
0.960
Why?
Stereotyping
1
2026
42
0.930
Why?
Health Promotion
4
2026
775
0.920
Why?
Reimbursement Mechanisms
3
2015
79
0.890
Why?
Colorado
16
2026
4553
0.800
Why?
Social Stigma
1
2026
172
0.790
Why?
Insurance, Health, Reimbursement
2
2014
98
0.780
Why?
Language
1
2026
323
0.750
Why?
Ambulatory Care Facilities
5
2013
269
0.750
Why?
Pregnancy, Unwanted
3
2009
15
0.700
Why?
Electronic Health Records
3
2026
1196
0.680
Why?
Attitude to Health
2
2014
430
0.660
Why?
Body Composition
7
2010
693
0.650
Why?
Analgesics, Opioid
4
2022
1149
0.640
Why?
Family Planning Services
2
2013
93
0.640
Why?
Contraception Behavior
2
2016
108
0.620
Why?
Substance-Related Disorders
2
2026
1102
0.610
Why?
HIV Infections
13
2026
3193
0.600
Why?
Contraception
5
2022
170
0.580
Why?
Papillomavirus Infections
6
2013
344
0.570
Why?
Influenza, Human
2
2014
624
0.540
Why?
Patient Participation
2
2019
439
0.530
Why?
Parental Consent
2
2014
25
0.520
Why?
Reverse Transcriptase Inhibitors
2
2008
87
0.510
Why?
Opiate Substitution Treatment
1
2019
188
0.490
Why?
Anti-HIV Agents
4
2009
912
0.490
Why?
Sex Education
1
2016
34
0.480
Why?
Adolescent
26
2026
22529
0.480
Why?
Papanicolaou Test
4
2013
35
0.460
Why?
Vaginal Smears
4
2013
54
0.460
Why?
Parents
2
2014
1403
0.440
Why?
Adolescent Health Services
1
2015
74
0.420
Why?
Minority Health
1
2014
18
0.410
Why?
Female
48
2026
78844
0.410
Why?
Financing, Government
1
2014
53
0.410
Why?
Social Values
1
2014
40
0.400
Why?
Patient Protection and Affordable Care Act
1
2014
103
0.390
Why?
Adult
34
2026
40777
0.380
Why?
Delivery of Health Care
3
2022
946
0.380
Why?
Pregnancy
15
2026
7202
0.370
Why?
Health Care Costs
2
2014
425
0.360
Why?
Humans
53
2026
145474
0.350
Why?
Geographic Information Systems
1
2011
45
0.340
Why?
Male
31
2026
72842
0.330
Why?
Stavudine
2
2008
6
0.330
Why?
Tumor Virus Infections
1
2011
51
0.330
Why?
Dideoxynucleosides
2
2008
24
0.330
Why?
Lamivudine
2
2008
65
0.320
Why?
Social Support
1
2014
646
0.300
Why?
Subcutaneous Fat
3
2010
79
0.300
Why?
Vaccines
1
2014
388
0.290
Why?
Anti-Retroviral Agents
4
2013
251
0.280
Why?
Public Health
1
2013
572
0.270
Why?
Zidovudine
1
2008
77
0.270
Why?
Vaccination
3
2013
1426
0.270
Why?
Insurance, Health
3
2015
310
0.250
Why?
HIV Protease Inhibitors
1
2007
69
0.250
Why?
Costs and Cost Analysis
2
2020
221
0.250
Why?
Health Status
1
2011
832
0.240
Why?
Indians, North American
1
2011
597
0.230
Why?
Program Evaluation
4
2026
943
0.230
Why?
Patient Compliance
1
2009
587
0.220
Why?
Primary Health Care
2
2014
1735
0.220
Why?
Papillomavirus Vaccines
3
2013
296
0.220
Why?
Respiratory Syncytial Virus, Human
1
2026
81
0.220
Why?
Natural Language Processing
1
2026
106
0.210
Why?
Antiretroviral Therapy, Highly Active
5
2010
279
0.210
Why?
Focus Groups
3
2026
569
0.210
Why?
Middle Aged
20
2019
36215
0.210
Why?
Risk Assessment
3
2013
3747
0.210
Why?
Respiratory Syncytial Virus Infections
1
2026
139
0.210
Why?
Pregnancy Complications, Infectious
2
2026
440
0.210
Why?
Attitude of Health Personnel
1
2012
1193
0.210
Why?
Community-Institutional Relations
2
2015
100
0.200
Why?
Health Knowledge, Attitudes, Practice
3
2026
1419
0.200
Why?
Physicians
1
2012
955
0.200
Why?
Diagnostic Errors
1
2005
178
0.200
Why?
HIV-1
4
2011
908
0.190
Why?
Pelvic Inflammatory Disease
1
2022
12
0.180
Why?
Follow-Up Studies
6
2017
5423
0.180
Why?
Intrauterine Devices
1
2022
29
0.180
Why?
Reproductive Health
1
2022
91
0.170
Why?
Long-Acting Reversible Contraception
1
2022
34
0.170
Why?
Human papillomavirus 16
2
2011
27
0.170
Why?
United States
9
2020
16098
0.170
Why?
Patient Acceptance of Health Care
3
2014
881
0.160
Why?
Heroin
1
2020
29
0.150
Why?
Allied Health Personnel
1
2020
53
0.150
Why?
Cardiovascular Diseases
1
2011
2187
0.150
Why?
Incidence
4
2013
2923
0.140
Why?
Prevalence
5
2013
2865
0.140
Why?
Multivariate Analysis
4
2009
1547
0.140
Why?
Drug Prescriptions
1
2020
288
0.140
Why?
HIV-Associated Lipodystrophy Syndrome
2
2010
9
0.130
Why?
Lipids
3
2009
707
0.130
Why?
Inpatients
1
2022
553
0.130
Why?
Uterine Cervical Neoplasms
2
2013
268
0.130
Why?
Young Adult
6
2026
14218
0.130
Why?
Cost-Benefit Analysis
2
2013
639
0.120
Why?
Adipose Tissue
4
2010
645
0.120
Why?
Child
5
2019
22707
0.120
Why?
Reminder Systems
1
2017
140
0.120
Why?
Medicaid
1
2020
467
0.120
Why?
Organizational Case Studies
1
2015
69
0.110
Why?
Drug Overdose
1
2020
374
0.110
Why?
Women's Health
2
2009
314
0.110
Why?
Inflammation
1
2026
2878
0.110
Why?
Health Plan Implementation
1
2015
141
0.100
Why?
Direct Service Costs
1
2014
9
0.100
Why?
Immunization Schedule
1
2015
186
0.100
Why?
Machine Learning
1
2020
587
0.100
Why?
Cervix Uteri
2
2011
50
0.100
Why?
National Health Programs
1
2013
23
0.100
Why?
AIDS Dementia Complex
1
2013
52
0.100
Why?
Sex Counseling
2
2003
4
0.100
Why?
Research Design
1
2019
1137
0.090
Why?
Models, Immunological
1
2013
99
0.090
Why?
Emergency Medical Services
1
2020
684
0.090
Why?
Cross-Sectional Studies
6
2013
5904
0.090
Why?
Clinical Trials as Topic
1
2017
1061
0.090
Why?
Health Services Needs and Demand
1
2014
280
0.090
Why?
Mass Screening
2
2013
1360
0.090
Why?
Uterine Cervical Dysplasia
2
2011
27
0.090
Why?
Time Factors
4
2013
7123
0.090
Why?
Medroxyprogesterone Acetate
1
2011
33
0.090
Why?
Human papillomavirus 18
1
2011
12
0.080
Why?
Schools
1
2014
448
0.080
Why?
Contraceptive Agents, Female
1
2011
80
0.080
Why?
Protease Inhibitors
1
2011
102
0.080
Why?
Self Efficacy
1
2014
410
0.080
Why?
Chi-Square Distribution
1
2011
527
0.080
Why?
Urban Population
2
2004
493
0.080
Why?
Hospitalization
1
2020
2460
0.080
Why?
Long QT Syndrome
1
2011
68
0.080
Why?
Health Education
1
2013
346
0.080
Why?
Regression Analysis
2
2009
1001
0.080
Why?
Risk-Taking
2
2002
323
0.070
Why?
Learning
1
2013
443
0.070
Why?
Life Style
1
2011
485
0.070
Why?
Ambulatory Care
1
2013
609
0.070
Why?
Neuropsychological Tests
1
2013
1134
0.070
Why?
Pilot Projects
1
2014
1891
0.070
Why?
Virology
1
2008
36
0.070
Why?
Cohort Studies
4
2008
6013
0.070
Why?
Odds Ratio
1
2009
1082
0.060
Why?
Osteoporosis
1
2009
238
0.060
Why?
Aged
6
2011
26153
0.060
Why?
Bone Density
1
2009
487
0.060
Why?
Risk Factors
5
2011
10885
0.060
Why?
Didanosine
1
2005
13
0.060
Why?
Practice Guidelines as Topic
1
2013
1581
0.060
Why?
Socioeconomic Factors
1
2009
1323
0.050
Why?
Genital Diseases, Female
1
2005
31
0.050
Why?
Vaginosis, Bacterial
1
2004
10
0.050
Why?
Prospective Studies
2
2009
8057
0.050
Why?
Community-Based Participatory Research
1
2026
168
0.050
Why?
Urban Health Services
1
2004
69
0.050
Why?
Fetal Blood
1
2026
327
0.050
Why?
Abortion, Therapeutic
1
2003
3
0.050
Why?
Spermatocidal Agents
1
2003
6
0.050
Why?
CD4 Lymphocyte Count
3
2010
280
0.050
Why?
Pregnancy Rate
1
2003
81
0.050
Why?
Catheters, Indwelling
1
2003
96
0.050
Why?
Killer Cells, Natural
1
2026
480
0.050
Why?
Hysterectomy
1
2003
138
0.050
Why?
Randomized Controlled Trials as Topic
2
2015
1747
0.050
Why?
Dendritic Cells
1
2026
499
0.050
Why?
Community Health Centers
1
2002
59
0.040
Why?
Program Development
2
2015
368
0.040
Why?
Longitudinal Studies
1
2009
2953
0.040
Why?
Contraceptive Agents
1
2022
66
0.040
Why?
Risk
1
2004
919
0.040
Why?
Postoperative Care
1
2003
286
0.040
Why?
Forecasting
1
2002
390
0.040
Why?
Insulin Resistance
2
2009
1244
0.040
Why?
Papillomaviridae
2
2013
116
0.040
Why?
Blood Glucose
2
2009
2341
0.040
Why?
Counseling
1
2003
400
0.040
Why?
Sensitivity and Specificity
1
2005
1997
0.040
Why?
Immunity, Innate
1
2026
835
0.040
Why?
Child, Preschool
1
2014
11853
0.040
Why?
Logistic Models
1
2004
2134
0.030
Why?
Absorptiometry, Photon
2
2010
277
0.030
Why?
Proportional Hazards Models
1
2002
1327
0.030
Why?
Insulin
2
2009
2512
0.030
Why?
Referral and Consultation
1
2003
867
0.030
Why?
Predictive Value of Tests
1
2002
2121
0.030
Why?
Retrospective Studies
3
2022
17291
0.030
Why?
Viral Load
2
2011
526
0.030
Why?
Electric Impedance
2
2007
108
0.030
Why?
Automation
1
2015
104
0.030
Why?
Motivation
1
2020
600
0.030
Why?
Cell Phone
1
2015
82
0.030
Why?
Infant, Newborn
1
2026
6447
0.030
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
2013
13
0.020
Why?
Epidemiological Monitoring
1
2013
69
0.020
Why?
Data Collection
1
2015
640
0.020
Why?
Infant
1
2026
10077
0.020
Why?
Coitus
1
2011
24
0.020
Why?
Sentinel Surveillance
1
2011
46
0.020
Why?
Sex Factors
2
2008
2105
0.020
Why?
Electrocardiography, Ambulatory
1
2011
63
0.020
Why?
Subcutaneous Fat, Abdominal
1
2010
15
0.020
Why?
Needs Assessment
1
2013
402
0.020
Why?
Radionuclide Imaging
1
2010
115
0.020
Why?
Sexual Partners
1
2011
193
0.020
Why?
Health Behavior
1
2015
789
0.020
Why?
Hip Joint
1
2009
173
0.020
Why?
Adolescent Behavior
1
2013
494
0.020
Why?
Drug Administration Schedule
1
2009
782
0.020
Why?
Lumbar Vertebrae
1
2009
252
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2008
138
0.020
Why?
Dose-Response Relationship, Drug
1
2011
2028
0.020
Why?
Gastrointestinal Diseases
1
2008
221
0.010
Why?
Polymerase Chain Reaction
1
2008
1041
0.010
Why?
Anthropometry
1
2005
206
0.010
Why?
Liver Diseases
1
2008
305
0.010
Why?
Metronidazole
1
2004
20
0.010
Why?
Prognosis
1
2013
4316
0.010
Why?
Verbal Behavior
1
2004
42
0.010
Why?
Treatment Outcome
2
2011
11772
0.010
Why?
Fractures, Bone
1
2009
428
0.010
Why?
Infectious Disease Transmission, Vertical
1
2004
194
0.010
Why?
Device Removal
1
2003
142
0.010
Why?
Anti-Infective Agents
1
2004
232
0.010
Why?
RNA, Viral
1
2005
692
0.010
Why?
Recurrence
1
2004
1138
0.010
Why?
Evidence-Based Medicine
1
2004
740
0.010
Why?
Smoking
1
2007
1472
0.010
Why?
Surveys and Questionnaires
1
2013
6066
0.010
Why?
Age Factors
1
2007
3342
0.010
Why?
Tomography, X-Ray Computed
1
2009
2769
0.010
Why?
Body Mass Index
1
2007
2445
0.010
Why?
Pain
1
2003
789
0.010
Why?
Shlay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)